title: Prenatal hypoxia programs changes in β-adrenergic signaling and postnatal cardiac contractile dysfunction.
abstract: Prenatal hypoxia leads to an increased risk of adult cardiovascular disease. We have previously demonstrated a programming effect of prenatal hypoxia on the cardiac β-adrenergic (βAR) response. The aim of this study was to determine 1) whether the decrease in βAR sensitivity in prenatally hypoxic 5-wk old chicken hearts is linked to changes in β1AR/β2ARs, Gαi expression and cAMP accumulation and 2) whether prenatal hypoxia has an effect on heart function in vivo. We incubated eggs in normoxia (N, 21% O2) or hypoxia from day 0 (H, 14% O2) and raised the posthatchlings to 5 wk of age. Cardiac β1AR/β2ARs were assessed through competitive binding of [(3)H]CGP-12177 with specific β1AR or β2AR blockers. Gαs and Gαi proteins were assessed by Western blot and cAMP accumulation by ELISA. Echocardiograms were recorded in anesthetized birds to evaluate diastolic/systolic diameter and heart rate and tissue sections were stained for collagen. We found an increase in relative heart mass, β1ARs, and Gαs in prenatally hypoxic hearts. cAMP levels after isoproterenol stimulation and collagen content was not changed in H compared with N, but in vivo echocardiograms showed systolic contractile dysfunction. The changes in βAR and G protein subtypes may be indicative of an early compensatory stage in the progression of cardiac dysfunction, further supported by the cardiac hypertrophy and systolic contractile dysfunction. We suggest that it is not the changes in the proximal part of the βAR system that causes the decreased cardiac contractility, but Ca(2+) handling mechanisms further downstream in the βAR signaling cascade.
authors.affiliation: AVIAN Behavioural Genomics and Physiology, IFM Biology, Linköping University, Linköping, Sweden.
authors.forename: I
authors.initials: I
authors.lastname: Lindgren
authors.forename: J
authors.initials: J
authors.lastname: Altimiras
mesh_terms: D000319:Adrenergic beta-Antagonists; D000818:Animals; D001481:Basal Metabolism; D002642:Chick Embryo; D000242:Cyclic AMP / Q000378:metabolism; D005355:Fibrosis / Q000209:etiology / Q000662:veterinary; D018507:Gene Expression Regulation, Developmental / Q000502:physiology; D006331:Heart Diseases / Q000209:etiology; D000860:Hypoxia; D009200:Myocardial Contraction / Q000502:physiology*; D009206:Myocardium / Q000378:metabolism*; D010100:Oxygen / Q000378:metabolism*; D011943:Receptors, Adrenergic, beta / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology*
chemical_list: D000319:Adrenergic beta-Antagonists; D011943:Receptors, Adrenergic, beta; D000242:Cyclic AMP; D010100:Oxygen
keywords: G proteins; developmental programming; heart failure; systolic dysfunction; β-adrenergic receptors